FDA Warns Chinese API Manufacturer Over Quality Management, Record-Keeping

Drug Industry Daily
A A
The FDA warned Chinese API manufacturer Changzhou Jintan Qianyao Pharmaceutical Raw Materials for inadequate quality management and record-keeping.

To View This Article:

Login

Subscribe To Drug Industry Daily